Residual plasma Epstein–Barr virus DNA after intensity-modulated radiation therapy is associated with poor outcomes in nasopharyngeal carcinoma
Article in Future Oncology (October 2023)
The most recent citing publications are shown below. View all 8 publications that cite this research output on Dimensions.
Prognostic effect of residual plasma Epstein–Barr viral DNA after induction chemotherapy for locoregionally advanced nasopharyngeal carcinoma
Article in Cancer Medicine (May 2023)
Assessment of Response to Different Induction Chemotherapy Regimens in Locally Advanced Nasopharyngeal Carcinoma
Article in Drug Design Development and Therapy (February 2023)